ADVERTISEMENT
Africanian
  • News
  • News 24/7
  • Politics
  • Business
  • Health
  • Sports
  • Travel
  • World
    • US
    • Russia
    • Europe
    • Asia
    • America
No Result
View All Result
Africanian
No Result
View All Result
Home Health

Health: @WHO recommends two new drugs to treat COVID-19

Today’s recommendations, forming the eighth update of WHO’s living guidelines on therapeutics and COVID-19, are based on evidence from seven trials involving over 4,000 patients with non-severe, severe, and critical COVID-19.

in Health, News
Reading Time: 2 mins read
0 0
0
Health: @WHO recommends two new drugs to treat COVID-19
0
SHARES
Share on FacebookShare on TwitterShare via Whatsapp

WHO has recommended two new drugs for COVID-19, providing yet more options for treating the disease. The extent to which these medicines will save lives depends on how widely available and affordable they will be.

The first drug, baricitinib, is strongly recommended for patients with severe or critical COVID-19. It is part of a class of drugs called Janus kinase (JAK) inhibitors that suppress the overstimulation of the immune system. WHO recommends that it is given with corticosteroids.

Baricitinib is an oral drug, used in the treatment of rheumatoid arthritis. It provides an alternative to other arthritis drugs called Interleukin-6 receptor blockers, recommended by WHO in July 2021.

WHO has also conditionally recommended the use of a monoclonal antibody drug, sotrovimab, for treating mild or moderate COVID-19 in patients who are at high risk of hospitalization. This includes patients who are older, immunocompromised, having underlying conditions like diabetes, hypertension, and obesity, and those unvaccinated.

Sotrovimab is an alternative to casirivimab-imdevimab, a monoclonal antibody cocktail recommended by WHO in September 2021. Studies are ongoing on the effectiveness of monoclonal antibodies against Omicron but early laboratory studies show that sotrovimab retains its activity.

More

Top 5 Reasons to be Optimistic About AI Development in Africa

Top 10 Jobs AI Will Take Over in the Next Decade in Africa

Benin: Petrol Prices Soar as Nigeria Moves to End Subsidy

The panel of experts developing the guidelines also looked at two other drugs for severe and critical COVID-19: ruxolitinib and tofacitinib. Given their uncertain effects, WHO made a conditional recommendation against their use.

WHO is in discussions with manufacturers to secure global supply capacity and equitable and sustainable access to the newly recommended therapeutics. The Access to COVID-19 Tools Accelerator (ACT-A) Therapeutics pillar has been engaging with pharmaceutical companies to seek comprehensive access plans for low- and middle-income countries, so that these treatments can be rapidly deployed everywhere, not just in rich countries. The ACT-A is also looking to expand licensing scope to make the products more affordable.

The two newly recommended drugs – baricitinib and sotrovimab – have been invited for WHO Prequalification, which assesses the quality, efficacy and safety of priority health products to increase access in lower income countries.

Source: WHO

africanian

africanian

Africanian, an Africa news media portal.

  • Trending
  • Comments
  • Latest
Sino-African Relations: Eventful Ceremony brings to a close Think Tank Forum

Sino-African Relations: Eventful Ceremony brings to a close Think Tank Forum

June 4, 2023
China-Africa Relations: the continent's finest in the Middle Kingdom

China-Africa Relations: the continent’s finest in the Middle Kingdom

May 27, 2023
Promoting Gender Equality in African Technology Hubs

Promoting Gender Equality in African Technology Hubs

May 29, 2023
Top 5 Reasons to be Optimistic About AI Development in Africa

Top 5 Reasons to be Optimistic About AI Development in Africa

June 5, 2023
Top 10 Jobs AI Will Take Over in the Next Decade in Africa

Top 10 Jobs AI Will Take Over in the Next Decade in Africa

June 5, 2023
Benin: Petrol Prices Soar as Nigeria Moves to End Subsidy

Benin: Petrol Prices Soar as Nigeria Moves to End Subsidy

June 4, 2023
Africanian

Copyright © 2022 Africanian.com.

Follow Us

No Result
View All Result
  • News
  • Politics
  • Business
  • Health
  • Sports
  • Entertainment
  • Tech
  • Travel
  • World

Copyright © 2022 Africanian.com.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Log In

Sign In

Forgot password?

Don't have an account? Register

Forgot password?

Enter your account data and we will send you a link to reset your password.

Back to Login

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Accept

Add to Collection

  • Public collection title

  • Private collection title

No Collections

Here you'll find all collections you've created before.